Is 1515.HK overvalued or undervalued?

1515.HK currently has a P/E ratio of 5.81. Relative to the sector average of 26.80, this suggests the stock may be undervalued. A higher P/E than peers means investors are paying more for each unit of earnings, often because they expect faster future growth. However, if that growth does not materialize, the stock can appear overvalued. A lower P/E may indicate weaker growth expectations or higher risk, but it can also signal a potential valuation discount.

How can I buy China Resources Medical Holdings Company Limited stock?

China Resources Medical Holdings Company Limited trades on HKSE. Investors in Latin America can buy it through international and regional brokerage and investment platforms. You simply need a valid government ID or passport to get started.

Can I buy fractional shares of 1515.HK?

Yes. Through fractional investing, you can invest exactly the amount you want, starting with as little as $1 or $5 USD (depending on what investment platform you use), and own a proportional piece of the company.

Does buying 1515.HK protect my money against local inflation?

Many investors in Latin America buy international stocks like 1515.HK to protect their purchasing power. Because 1515.HK is priced in foreign currency, your investment is tied to a hard currency. If your local currency devalues against the foreign currency, usually USD or Euro, the underlying value of your stock portfolio remains protected from local inflation.

Do I need a foreign bank account or a Visa to buy 1515.HK shares?

No. A common misconception is that you need a foreign bank account or a foreign visa to invest in international stocks. Today, modern investment platforms allow you to fund your account using local bank transfers or local payment methods right from your home country.

Is 1515.HK a suitable investment for my portfolio?

There is no universal answer, since fit depends on your situation, not just the stock. Think about three things: how well 1515.HK diversifies what you already own, whether you can stomach its price swings given your risk tolerance, and how long you plan to stay invested. As a rule, a single stock works best as one piece of a broader asset allocation and with a multi-year time horizon. This is general information, not personalized financial advice.

All stocks1515.HK

China Resources Medical Holdings Company Limited

HK$2.32+HK$0.02+0.87%

HKSE / HKD

Market cap

HK$2.9B

P/E

5.8

EPS (TTM)

HK$0.05

Dividend yield

6.66%

Beta

0.57

1Y return

-33.52%

Deposit US$200 and get US$50 for freeT&C apply. Your capital is at risk.Invest with

Compare, tap a companyup to 2 at once

Deposit US$200 and get US$50 for freeT&C apply. Your capital is at risk.Invest with

Financials

The numbers behind the company

Revenue vs net income

RevenueNet income

$700M2021

$1.1B2022

$1.4B2023

$1.3B2024

$1.3B2025

Financial health

Gross margin

Operating margin

ROE

ROA

Debt to equity0.13Low
Current ratio0.67
Cash ratio0.24
Net margin4.6%
Free cash flow—

Valuation

Is it expensive right now

P/E vs the market

scale 0–50

0153050

1515.HK5.8
Healthcare sector median26.8
S&P 50022.0

Trades about 78% below its sector, cheaper than its peers on earnings.

Ratios

PEG-0.72
Price to book0.37
EPS (TTM)HK$0.05
Payout ratio3,929%
FCF yield23.16%

Range & risk

HK$2.29HK$3.50

Trading in the lower third of its 52-week band

Beta0.57

Profile

What China Resources Medical Holdings Company Limited actually does

Operating as an investment holding firm, China Resources Medical Holdings Company Limited delivers a spectrum of healthcare services, encompassing general medical care, hospital administration, and advisory functions within the People's Republic of China. Its business activities are structured into three main divisions: hospitals it directly owns, facilities managed under Invest-Operate-Transfer (IOT) or Operate-Transfer (OT) agreements, and other ancillary operations. The company further provides group purchasing solutions and various services derived from its hospital network. A key component of its strategy involves managing and operating external hospitals and clinics through its IOT model. Additionally, the enterprise is active in the sale of pharmaceuticals, medical apparatus, medical consumables, and specialized equipment. Established in 2007, the company adopted its current name, China Resources Medical Holdings Company Limited, in October 2018, having previously been known as China Resources Phoenix Healthcare Holdings Company Limited. Its corporate headquarters are located in Beijing, People's Republic of China.

CEO

Chuang Zhang

Employees

19,182

Headquarters

Beijing, BE

Founded

2013-11-29

Company website

If you had invested a decade ago

Loading the full price history…

Run your own numbers

Past performance is not a forecast.

ETFs

Own it inside an ETF instead

Vanguard S&P 500

Vanguard Total Stock Market

Vanguard Total World Stock

Invesco QQQ

SPDR S&P 500

iShares Russell 2000

Community sentiment

Bullish—

Distribution

Bearish0%
Neutral0%
Bullish0%

Track it without buyingTrack it

no account needed

Save 1515.HK and get told when something moves.

Get updates

A clear, direct weekly summary.

Keep looking

Q&A

Questions people ask

1515.HK has a beta of 0.57, which indicates how sensitive it has historically been to movements in its broader market. A beta below 1 indicates lower relative volatility than the market. Beta is based on historical data and does not predict future performance.

China Resources Medical Holdings Company Limited